EyePoint (EYPT) Other Non-Current Assets (2011 - 2026)
EyePoint (EYPT) reported Other Non-Current Assets of $9.3 million for Q1 2026, up 6102.67% on a YoY basis from $150000.0 in Q1 2025, and up 6102.67% sequentially from $150000.0 in Q4 2025.
EyePoint (EYPT) Other Non-Current Assets (2011 - 2026) Analysis & Trends
EyePoint (EYPT) has 16 years of Other Non-Current Assets data on file, last reported at $9.3 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 6102.67% year-over-year to $9.3 million; the trailing twelve-month figure through Mar 2026 stood at $9.3 million (up 6102.67% YoY), and the FY2025 full-year result was $150000.0, down 97.43% from the prior year.
- Other Non-Current Assets grew to $9.3 million in Q1 2026, from $150000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $9.3 million in Q1 2026 to a low of $150000.0 in Q1 2022.
- A 5-year average of $1.8 million and a median of $150000.0 in 2022 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets slumped 97.43% in 2025 and jumped 6102.67% in 2026, its largest moves.
- Tracing EYPT's Other Non-Current Assets over 5 years: stood at $150000.0 in 2022, then changed by 0.0% to $150000.0 in 2023, then soared by 3788.0% to $5.8 million in 2024, then tumbled by 97.43% to $150000.0 in 2025, then jumped by 6102.67% to $9.3 million in 2026.
- Business Quant data shows EYPT's Other Non-Current Assets at $9.3 million in Q1 2026, $150000.0 in Q4 2025, and $5.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | 9.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.30 Mn |
| Dec 31, 2025 | 150,000.00 |
| Sep 30, 2025 | 5.92 Mn |
| Jun 30, 2025 | 5.90 Mn |
| Mar 31, 2025 | 150,000.00 |
| Dec 31, 2024 | 5.83 Mn |
| Sep 30, 2024 | 150,000.00 |
| Jun 30, 2024 | 150,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Sep 30, 2023 | 150,000.00 |
| Jun 30, 2023 | 150,000.00 |
| Mar 31, 2023 | 150,000.00 |
| Dec 31, 2022 | 150,000.00 |
| Sep 30, 2022 | 150,000.00 |
| Jun 30, 2022 | 150,000.00 |
| Mar 31, 2022 | 150,000.00 |
| Dec 31, 2021 | 150,000.00 |
| Sep 30, 2021 | 150,000.00 |
| Jun 30, 2021 | 150,000.00 |
| Mar 31, 2021 | 150,000.00 |